IBDEI1GO ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23369,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,23369,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,23370,0)
 ;;=C81.99^^105^1173^21
 ;;^UTILITY(U,$J,358.3,23370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23370,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites,Unspec
 ;;^UTILITY(U,$J,358.3,23370,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,23370,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,23371,0)
 ;;=C85.80^^105^1173^71
 ;;^UTILITY(U,$J,358.3,23371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23371,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma,Unspec Site NEC
 ;;^UTILITY(U,$J,358.3,23371,1,4,0)
 ;;=4^C85.80
 ;;^UTILITY(U,$J,358.3,23371,2)
 ;;=^5001721
 ;;^UTILITY(U,$J,358.3,23372,0)
 ;;=C85.89^^105^1173^70
 ;;^UTILITY(U,$J,358.3,23372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23372,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma,Extranodal/Solid Organ Sites NEC
 ;;^UTILITY(U,$J,358.3,23372,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,23372,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,23373,0)
 ;;=C90.01^^105^1173^65
 ;;^UTILITY(U,$J,358.3,23373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23373,1,3,0)
 ;;=3^Multiple Myeloma in Remission
 ;;^UTILITY(U,$J,358.3,23373,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,23373,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,23374,0)
 ;;=C91.90^^105^1173^32
 ;;^UTILITY(U,$J,358.3,23374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23374,1,3,0)
 ;;=3^Lymphoid Leukemia,Unspec
 ;;^UTILITY(U,$J,358.3,23374,1,4,0)
 ;;=4^C91.90
 ;;^UTILITY(U,$J,358.3,23374,2)
 ;;=^5001780
 ;;^UTILITY(U,$J,358.3,23375,0)
 ;;=C92.90^^105^1173^66
 ;;^UTILITY(U,$J,358.3,23375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23375,1,3,0)
 ;;=3^Myeloid Leukemia,Unspec
 ;;^UTILITY(U,$J,358.3,23375,1,4,0)
 ;;=4^C92.90
 ;;^UTILITY(U,$J,358.3,23375,2)
 ;;=^5001810
 ;;^UTILITY(U,$J,358.3,23376,0)
 ;;=D04.9^^105^1173^9
 ;;^UTILITY(U,$J,358.3,23376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23376,1,3,0)
 ;;=3^Carcinoma in Situ of Skin,Unspec
 ;;^UTILITY(U,$J,358.3,23376,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,23376,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,23377,0)
 ;;=D05.91^^105^1173^5
 ;;^UTILITY(U,$J,358.3,23377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23377,1,3,0)
 ;;=3^Carcinoma in Situ of Breast,Right,Unspec
 ;;^UTILITY(U,$J,358.3,23377,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,23377,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,23378,0)
 ;;=D05.92^^105^1173^3
 ;;^UTILITY(U,$J,358.3,23378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23378,1,3,0)
 ;;=3^Carcinoma in Situ of Breast,Left,Unspec
 ;;^UTILITY(U,$J,358.3,23378,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,23378,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,23379,0)
 ;;=D05.01^^105^1173^29
 ;;^UTILITY(U,$J,358.3,23379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23379,1,3,0)
 ;;=3^Lobular Carcinoma in Situ of Breast,Right
 ;;^UTILITY(U,$J,358.3,23379,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,23379,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,23380,0)
 ;;=D05.02^^105^1173^28
 ;;^UTILITY(U,$J,358.3,23380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23380,1,3,0)
 ;;=3^Lobular Carcinoma in Situ of Breast,Left
 ;;^UTILITY(U,$J,358.3,23380,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,23380,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,23381,0)
 ;;=D05.11^^105^1173^23
 ;;^UTILITY(U,$J,358.3,23381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23381,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ of Breast,Right
